Paper Titles

The Photocatalysis Properties of Heterostructured WO₃-TiO₂ Composite Prepared by Waste WC-TiC Hardmetal
p.603

Study on Performance of Transition Metal-Doped Catalysts for DeNOx at Low-Temperature
p.612

The Application of Electromagnetic Metamaterials for Wireless Power Transfer
p.619

Construction of Three-Dimensional Scaffold for Tissue Engineered Heart Valves
p.627

Advances in Biomaterial’s Modification and Thrombosis Inhibition
p.635

Degradation Modeling Research of Biodegradable Tissue Engineering Scaffold
p.642

Post-Processing of Chitosan Based Nanofibers Prepared by Electrospinning
p.652

Effect of Sodium Alginate Content on the Properties of Chemical-Ionic Cross-Linked Hydrogel
p.663

Effect of Fiber Treatment/Starch Plasticization on Structure and Mechanical Properties of Biomass Cushion Packaging Material
p.669

HomeAdvanced Materials ResearchAdvanced Materials Research Vol. 873Advances in Biomaterial’s Modification and...

Advances in Biomaterial’s Modification and Thrombosis Inhibition

Article Preview

Abstract:

With the development of modern medical technology, the clinical range of biomaterial applications have gradually expanded. However, bioactivity on the surface of biomaterials may be reduced and induce thrombus formation that will not only cause serious dysfunction of the biological materials, but can also affect the host. Modification of these biological materials can thus help to retain the biological activity on the surface of the material and inhibit thrombus formation, which underlines the importance of their clinical application. The current review will address the modification of biomaterials and inhibition of thrombosis on the surface of biomaterials.

You might also be interested in these eBooks

The Eighth China National Conference on Functional Materials and Applications

Info:

Periodical:

Advanced Materials Research (Volume 873)

Pages:

635-641

DOI:

https://doi.org/10.4028/www.scientific.net/AMR.873.635

Citation:

Cite this paper

Online since:

December 2013

Authors:

Shi Dong Hu*, Bin En Nie, Jian Liang Zhou

Keywords:

Biomaterial, Modification, Thrombus

Export:

RIS, BibTeX

Price:

Permissions CCC:

Request Permissions

Permissions PLS:

Request Permissions

Сopyright:

© 2014 Trans Tech Publications Ltd. All Rights Reserved

Share:

Citation:

* - Corresponding Author

[1] Jordan S.W., Chaikof E. L: Novel thromboresistant materials. J Vasc Surg, Vol. 45A (2007) p.104–A115.

[2] Kidane A.G., Salacinski H., Tiwari A., et al: Anticoagulant and antiplatelet agents: their clinical and device application(s) together with usages to engineer surfaces. Biomacromolecules, Vol. 5 (2004) p.798–813.

DOI: 10.1021/bm0344553

[3] Kasimir M.T., Rieder E., Seebacher G., et al: Decellularization does not eliminate thrombogenicity and inflammatory stimulation in tissue-engineered porcine heart valves. J Heart Valve Dis. Vol. 15 (2006) No. 2 pp.278-86.

[4] Kasimir M.T., Weigel G., Sharma J., et al: The decellularized porcine heart valve matrix in tissue engineering: platelet adhesion and activation. Thromb Haemost, Vol. 94 (2005) pp.562-567.

DOI: 10.1160/th05-01-0025

[5] Dohmen P.M., Ozaki S., Nitsch R., et al: A tissue engineered heart valve implanted in a juvenile sheep model. Med Sci Monit, Vol. 9 (2003) p. BR97-BR104.

[6] Dohmen P.M., Lembcke A., Hotz H., et al: Ross operation with a tissue-engineered heart valve. Ann Thorac Surg, Vol. 74 (2002) pp.1438-1442.

DOI: 10.1016/s0003-4975(02)03881-x

[7] Schopka S., Schmid T., Schmid C., et al: Current strategies in cardiovascular biomaterial functionalization. Materials, Vol. 3 (2010) pp.638-655.

DOI: 10.3390/ma3010638

[8] Breuer C.K., Mettler B.A., Anthony T., et al: Application of tissue-engineering principlestoward the development of a semilunar heart valve substitute. Tissue Eng, Vol. 10 (2004) pp.1725-1736.

DOI: 10.1089/ten.2004.10.1725

[9] Bordenave L., Fernandez P., Remy-Zolghadri M., et al: In vitro endothelialized ePTFE prostheses: Clinical update 20 years after the first realization. Clin Hemorheol Microcirc, Vol. 33 (2005) p.227–234.

[10] Kleinman H.K., Philp D., Hoffman M.P.: Role of the extracellular matrix in morphogenesis. Current Opinion in Biotechnology, Vol. 14 (2003) No. 5 p.526–532.

DOI: 10.1016/j.copbio.2003.08.002

[11] Shi J.W., Dong N.G., Sun Z.Q.: Immobilization of Decellularized Valve Scaffolds with Arg-Gly-Asp-containing Peptide to Promote Myofibroblast Adhesion. J Huazhong Univ Sci Technol, Vol. 29 (2009) No. 4 pp.503-507.

DOI: 10.1007/s11596-009-0422-8

[12] Lutolf M.P., Hubbell J.A.: Synthetic biomaterials as instructive extracellular microenvironments for morphogenesis in tissue engineering. Nature Biotechnology, Vol. 23 (2005) p.47–55.

DOI: 10.1038/nbt1055

[13] Dong X.C., Wei X.F., Yi W., et al: RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering. J Mater Sci: Mater Med, Vol. 20 (2009) pp.2327-2336.

DOI: 10.1007/s10856-009-3791-4

[14] ]Hong H., Dong G.N., Shi W.J., et al: Fabrication of biomatrix/polymer hybrid scaffold for heart valve tissue engineering in vitro. ASAIO J, Nov-Dec Vol. 54(2008) No. 6 pp.627-632.

DOI: 10.1097/mat.0b013e31818965d3

[15] DENG Cheng, DONG Nianguo, SHI Jiawei et al: The research of decelluarized valve scaffolds modified by polyethylene glycol microspheres loading transforming growth factor-β1J Clin Cardiol (China), Jan 2010, Vol 26, No1.

[16] DONG Nian-guo，YE Xiao-feng，SUN Zong-quan et al: Experimental study on mechanical properties of decellularized porcine aortic valve and efects of preomti, g methods of biological scafold on histoeompafibility J Clin Cardiol (China), Jan 2010, Vol 26, No 1.

[17] Hersel U., Dahmen C., Kessler H.: RGD modified polymers: biomaterials for stimulated cell adhesion and beyond. Biomaterials, Vol. 24 (2003) pp.4385-4415.

DOI: 10.1016/s0142-9612(03)00343-0

[18] Li C.W., Zheng Q.X., Guo X.D., et al: Combined Use of RGD-peptide Modified PLGA and TGF-βl Gene Transfected MSCs to Improve Cell Biobehaviors in vitro. J Huazhong Univ Sci Technol, Vol. 29 (2009) No. 5 pp.592-598.

DOI: 10.1007/s11596-009-0512-7

[19] Wang H., Ma L., Yang S.H., et al: Effect of RGD-modified Silk Material on the Adhesion and Proliferation of Bone Marrow-derived Mesenchymal Stem Cells. J Huazhong Univ Sci Technol, Vol. 29 (2009) No. 1 pp.80-83.

DOI: 10.1007/s11596-009-0117-1

[20] Alobaid N., Salacinski H.J., Sales K.M., et al: Nanocomposite Containing Bioactive Peptides Promote Endothelialisation by Circulating Progenitor Cells: An In vitroEvaluation. European Journal of Vascular ＆ Endovascular Surgery, Vol. 32 (2006).

DOI: 10.1016/j.ejvs.2005.11.034

[21] Tran N.Q., Joung Y.K., Lih E., et al: RGD-conjugated In Situ forming hydrogels as cell-adhesive injectable scaffolds. Macromolecular Research, Vol. 19 (2011) No. 3 pp.300-306.

DOI: 10.1007/s13233-011-0309-y

[22] Stegemann J.P., Kaszuba S.N., Rowe S.L.: Review: Advances in Vascular Tissue Engineering Using Protein-Based Biomaterials. Tissue Eng, Vol. 13 (2007) No. 11 p.2601–2613.

DOI: 10.1089/ten.2007.0196

[23] Heilshorn S.C., DiZio K.A., Welsh E.R., et al: Endothelial cell adhesion to the fibronectin CS5 domain in artificial extracellular matrix proteins. Biomaterials, Vol. 24 (2003) No. 23 p.4245–4252.

DOI: 10.1016/s0142-9612(03)00294-1

[24] Shi J.W., Dong N.G., Sun Z.Q.: Immobilization of Decellularized Valve Scaffolds with Arg-Gly-Asp-containing Peptide to Promote Myofibroblast Adhesion. J Huazhong Univ Sci Technol, Vol. 29 (2009) No. 4 pp.503-507.

DOI: 10.1007/s11596-009-0422-8

[25] Dong X.C., Wei X.F., Yi W., et al: RGD-modified acellular bovine pericardium as a bioprosthetic scaffold for tissue engineering. J Mater Sci: Mater Med, Vol. 20 (2009) pp.2327-2336.

DOI: 10.1007/s10856-009-3791-4

[26] Li C.W., Zheng Q.X., Guo X.D., et al: Combined Use of RGD-peptide Modified PLGA and TGF-βl Gene Transfected MSCs to Improve Cell Biobehaviors in vitro. J Huazhong Univ Sci Technol, Vol. 29 (2009) No. 5 pp.592-598.

DOI: 10.1007/s11596-009-0512-7

[27] Wang H., Ma L., Yang S.H., et al: Effect of RGD-modified Silk Material on the Adhesion and Proliferation of Bone Marrow-derived Mesenchymal Stem Cells. J Huazhong Univ Sci Technol, Vol. 29 (2009) No. 1 pp.80-83.

DOI: 10.1007/s11596-009-0117-1

[28] Hersel U., Dahmen C., Kessler H.: RGD modified polymers: Biomaterials for stimulated cell adhesion and beyond. Biomaterials, Vol. 24 (2003) pp.4385-4415.

DOI: 10.1016/s0142-9612(03)00343-0

[29] Tran N.Q., Joung Y.K., Lih E., et al: RGD-conjugated In Situ forming hydrogels as cell-adhesive injectable scaffolds. Macromolecular Research, Vol. 19 (2011) No. 3 pp.300-306.

DOI: 10.1007/s13233-011-0309-y

[30] Hatakeyama H., Kikuchi A., Yamato M., et al: Bio-functionalized thermoresponsive interfaces facilitating cell adhesion and proliferation. Biomaterials, Vol. 27 (2006) No. 29 pp.5069-5078.

DOI: 10.1016/j.biomaterials.2006.05.019

[31] Leung D.W., Cachines G., Kuang W.J., et al: Vascular endothelial growth factor issecreted angiogenic mitogen. Science, Vol. 246 (1989) p.1306.

DOI: 10.1126/science.2479986

[32] Neufeld G., Cohen T., Stela G., et al: Vascular endothelial growth factor(VEGF) and itsreceptors. FASEB J, Vol. 13 (1999) pp.9-22.

[33] Holmes K., Roberts O.L., Thomas A,M., et al: Vascular endothelial growth factor receptor-2: structure，function，intracellular signaling and therapeutic inhibition．Cell Signal, Vol. 19 (2007) No. 10 p.2003~(2012).

DOI: 10.1016/j.cellsig.2007.05.013

[34] Knetsch M.L.W., Koole L.H.: VEGF-E enhances endothelialization and inhibits thrombus formation on polymeric surfaces. Journal of Biomedical Materials Research, Vol. 93A (2010) No. 1 pp.77-85.

DOI: 10.1002/jbm.a.32538

[35] Müller S., Koenig G., Charpiot A., et al: VEGF-Functionalized Polyelectrolyte Multilayers as Proangiogenic Prosthetic Coatings. Advance Functional Materials, Vol. 18 (2008) No. 12 pp.1767-1775.

DOI: 10.1002/adfm.200701233

[36] Shen Y.H., Shoichet M.S., Radisic M.: Vascular endothelial growth factor immobilized in collagen scaﬀold promotes penetration and proliferation of endothelial cells. Acta Biomaterialia, Vol. 4 (2008) pp.477-489.

DOI: 10.1016/j.actbio.2007.12.011

[37] Poter A.M., Klinge C.M., Gobin A.S.: Biomimetic Hydrogels with VEGF induce angiogenic processes in both hUVEC and hMEC. Biomacromolecules, Vol. 12 (2011) pp.242-246.

DOI: 10.1021/bm101220b

[38] Zisch A.H., Lutolf M.P., Ehrbar M., et al: Cell-demanded release of VEGF from synthetic, biointeractive cell-ingrowth matrices for vascularized tissue growth. FASEB J, Vol. 17 (2003) p.2260–2262.

DOI: 10.1096/fj.02-1041fje

[39] Poh C.K., Shi Z.L., Lim T.Y., et al: The effect of VEGF functionalization of titanium on endothelial cells in vitro. Biomaterials, Vol. 31 (2010) No. 7 pp.1578-1585.

DOI: 10.1016/j.biomaterials.2009.11.042

[40] Leach . LK., Kaigle D., Wang Z., et al: Coating of VEGF-releasing scaffolds with bioactive glass for angiogenesis and bone regeneration. Biomaterials, Vol. 27 (2006) No. 17 pp.3249-3255.

DOI: 10.1016/j.biomaterials.2006.01.033

[41] Walpoth B.H., Zammaretti P., Cikirikcioglu M., et al: Enhanced intimal thickening of expanded polytetrafluoroethylene grafts coated with fibrin or fibrin-releasing vascular endothelial growth factor in the pig carotid artery interposition model. J Thorac CardioVasc Surg, Vol. 133 (2007).

DOI: 10.1016/j.jtcvs.2007.01.029

[42] Bunting S., Moncada S., Vane J.R.: Antithrombotic properties of vascular endothelium. Lancet, Vol. 2 (1977) p.1075–1076.

DOI: 10.1016/s0140-6736(77)91906-7

[43] De Mel A., Jell G., Stevens M.M., et al: Biofunctionalization of biomaterials for accelerated in situ endothelialization: a review. Biomacromolecules, Vol. 9 (2008) p.2969–2679.

DOI: 10.1021/bm800681k

[44] Melero-Martin J.M., Khan Z.A., Picard A., et al: In vivo vasculogenic potential of human blood-derived endothelial progenitor cells. Blood, Vol. 109 (2007) p.4761–4768.

DOI: 10.1182/blood-2006-12-062471

[45] Rothmans J.I., Heyligers J.M.M., Stroes E.S.G., et al: Endothelial progenitor cell-seeded grafts: Rash and risky. Can J Cardiol, Vol. 22 (2006) p.929–932.

DOI: 10.1016/s0828-282x(06)70311-7

[46] Dohmen P.M., Lembcke A., Hotz H., et al: Ross operation with a tissue-engineered heart valve. Ann Thorac Surg, Vol. 74 (2002) pp.1438-1442.

DOI: 10.1016/s0003-4975(02)03881-x

[47] Schmidt D., Breymann C., Weber A., et al: Umbilical cord blood derived endothelial progenitor cells for tissue engineering of vascular grafts. Ann Thorac Surg, Vol. 78 (2004) p.2094-(2098).

DOI: 10.1016/j.athoracsur.2004.06.052

[48] Schmidt D., Mol A., Neuenschwander S., et al: Living patches engineered from human umbilical cord derived fibroblasts and endothelial progenitor cells. Eur J Cardiothorac Surg, Vol. 27 (2005) pp.795-800.

DOI: 10.1016/j.ejcts.2005.01.064

[49] Kaushal S., Amiel G.E., Guleserian K.J., et al: Functional small diameter neovessels created using endothelial progenitor cells expanded in vivo. Nat Med, Vol. 7 (2001) pp.1035-1040.

DOI: 10.1038/nm0901-1035

[50] Avci-Adali M., Paul A., Ziemer G., et al: New strategies for in vivo tissue engineering by mimicry of homing factors for self-endothelialization of blood contacting materials. Biomaterials, Vol. 29 (2008) p.3936–3945.

DOI: 10.1016/j.biomaterials.2008.07.002

[51] Rodenberg E.J., Pavalko F.M.: Peptides Derived from Fibronectin Type III Connecting Segments Promote Endothelial Cell Adhesion but Not Platelet Adhesion: Implications in Tissue-Engineered Vascular Grafts. Tissue Eng, Vol. 13 (2007).

DOI: 10.1089/ten.2007.0037

[52] Moncada S., Palmer R.M., Higgs E.A.: The discovery of nitric oxide as the endogenous nitrovasodilator. Lancet, Vol. 2 (1987) p.1057–1058.

[53] Lev E.I., Estrov Z., Aboulfatova K., et al: Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix. Thromb Haemost, Vol. 96(2006) p.498–504.

DOI: 10.1160/th06-05-0250